Skip to main content

Table 2 Diagnostic performance of SNAP-25, Ng, and other surrogate biomarkers

From: Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias

 

CJD vs. np-RPD

Atypical CJDa vs. np-RPD

 

AUC

(95% CI)

Sensitivity (95%CI)

Specificity (95% CI)

Cut-off (pg/ml)

AUC

(95% CI)

Sensitivity (95%CI)

Specificity (95% CI)

Cut-off (pg/ml)

t-tau

0.878 (0.845–0.901)

78.8% (72.9–83.7)

84.9% (79.5–89.1)

1770

0.774 (0.719–0.830)

84.6% (73.9–91.4)

63.8% (57.2–70.0)

993.5

14–3-3

0.853 (0.816–0.889)

83.8% (78.3–88.0)

75.1% (68.9–80.4)

21,750

0.733 (0.676–0.791)

81.5% (70.4–9.1)

65.7% (59.1–71.7)

14,850

NfL

0.649 (0.593–0.705)

89.6% (84.9–92.9)

51.9% (45.2–58.5)

2245

0.626 (0.560–0.691)

87.5% (77.2–93.5)

51.8% (45.1–58.5)

2245

SNAP-25

0.902 (0.873–0.931)

84.7% (79.3–88.8)

85.4% (80.0–89.5)

198.7

0.792 (0.729–0.854)

75.3% (63.6–84.2)

78.4% (72.4–83.4)

163.8

Ngb

0.697 (0.626–0.767)

54.1% (45.2–62.6)

77.4% (67.9–84.7)

793.5

0.643 (0.545–0.741)

84.0% (70.6–92.0)

46.2% (36.4–56.3)

350.0

t-tau/p-tau

0.884 (0.851–0.916)

92.2% (87.8–95.0)

70.4% (63.8–76.2)

17.80

0.778 (0.725–0.830)

98.4% (91.5–99.9)

63.6% (56.8–69.8)

11.90

SNAP-25/p-tau

0.924 (0.900–0.948)

92.2% (87.8–95.0)

79.6% (73.6–84.5)

2.950

0.812 (0.760–0.864)

77.8% (66.0–86.2)

79.6% (73.6–84.5)

2.950

 

CJD vs. rp-ND

CJD vs. non-neurodegenerative np-RPD

 

AUC

(95% CI)

Sensitivity (95%CI)

Specificity (95% CI)

Cut-off (pg/ml)

AUC

(95% CI)

Sensitivity (95%CI)

Specificity (95% CI)

Cut-off (pg/ml)

t-tau

0.928 (0.899–0.957)

77.9% (72.0–82.9)

94.0% (87.6–97.2)

1808

0.826 (0.775–0.877)

78.8% (72.9–83.7)

76.5% (67.2–83.8)

1768

14–3-3

0.942 (0.916–0.967)

86.0% (80.8–89.9)

91.0% (83.9–95.2)

18,850

0.771 (0.712–0.831)

83.8% (78.4–88.0)

60.2% (50.3–69.3)

21,750

NfL

0.839 (0.782–0.896)

89.6% (84.9–92.9)

75.2% (66.0–82.6)

2245

0.512 (0.429–0.595)

90.0% (85.4–93.3)

34.0% (25.4–43.9)

15,450

SNAP-25

0.916 (0.886–0.946)

80.6% (74.9–85.3)

94.0% (87.6–97.2)

214.2

0.887 (0.850–0.925)

84.7% (79.4–88.8)

81.6% (72.8–88.0)

195.3

Ngb

0.733 (0.652–0.813)

54.1% (45.2–62.6)

84.4% (71.2–92.2)

787.0

0.669 (0.573–0.765)

86.0% (78.8–91.1)

46.5% (32.5–61.0)

339.0

t-tau/p-tau

0.966 (0.943–0.989)

98.6% (96.0–99.6)

88.0% (80.1–93.0)

11.65

0.794 (0.736–0.851)

63.7% (57.1–69.8)

82.6% (73.6–89.0)

51.40

SNAP-25/p-tau

0.971 (0.954–0.987)

92.2% (87.9–95.0)

93% (86.2–96.6)

2.950

0.869 (0.829–0.910)

78.4% (72.5–83.3)

83.7% (74.8–89.8)

4.950

  1. Abbreviations: AUC area under the curve, CI confidence interval, CSF cerebrospinal fluid, NfL neurofilament light chain, Ng neurogranin, np-RPD non-prion rapidly progressive dementia, p-tau phospho-tau181, rp-ND neurodegenerative np-RPD, SNAP-25 synaptosomal-associated protein 25; t-tau, total tau
  2. asCJD subtypes MV2K, MM(V)2C, MM2T, and VV1 are included
  3. bAUC values for Ng were calculated considering a cohort of 215 patients (122 CJD, 93 np-RPD)